Lymphopenia during chemoradiation—foe or friend

BACKGROUND: Severe lymphopenia during treatment is considered to be a poor prognostic factor. The current literature lacks information regarding its impact on various outcomes in locally advanced head-and-neck cancer patients in a prospective setting. METHODS: We recently published a randomised stud...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ecancermedicalscience
Hlavní autoři: Patil, Vijay M, Singh, Gunjesh Kumar, Noronha, Vanita, Joshi, Amit, Menon, Nandini, Lashkar, Sarbani Ghosh, Mathrudev, Vijayalakshmi, Satam, Kavita Nawale, Mukadam, Sadaf Abdulazeez, Prabhash, Kumar
Médium: Artigo
Jazyk:Inglês
Vydáno: Cancer Intelligence 2020
Témata:
Short Communication
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7581337/
https://ncbi.nlm.nih.gov/pubmed/33144877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2020.1109
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky